Tag: Viking Therapeutics

Investors in Viking Therapeutics are currently focused on a specific calendar event rather than breaking news. The biopharmaceutical firm is ...

Shares of Viking Therapeutics are trading within a consolidated range as the market anticipates significant corporate news. The biotechnology firm ...

Biopharmaceutical company Viking Therapeutics has moved its lead obesity treatment candidate into the final stage of clinical development, following the ...

While Viking Therapeutics shares continue to navigate a challenging correction, having shed approximately 15% over the past month, a recent ...

Viking Therapeutics has filed a mandatory disclosure with the U.S. Securities and Exchange Commission (SEC) detailing the compensation package for ...

Shares of Viking Therapeutics experienced a significant rally in today's trading session, marking a notable recovery after a volatile period ...

Shares of Viking Therapeutics have posted significant gains, fueled by renewed takeover speculation within the obesity drug sector. This sentiment ...

Shares of Viking Therapeutics closed the week on a strong note, propelled by emerging challenges facing a major competitor in ...

Shares of Viking Therapeutics experienced a significant surge this week, driven by a series of strategic updates and a notable ...

Shares of Viking Therapeutics, a clinical-stage biotechnology firm, experienced a significant rally, closing at $34.34 with a gain of approximately ...